Treatment of Relapsed/Refractory Myeloma (excluding T-cell redirection therapy)
Characterization and management of ocular events in patients treated with belantamab mafodotin plus pomalidomide and dexamethasone in the DREAMM-8 study
Hang Quach, MBBS(Hons) SpecCertOC FRACP FRCPA MD (she/her/hers)
Director of Haematology
St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia
Melbourne, Victoria, Australia